JPRN-UMIN000014581已完成未知
A clinical study for patients with moderate to severe Alzheimer's disease using Memantine hydrochloride OD tablet. - A clinical study for patients with moderate to severe Alzheimer's disease using Memantine hydrochloride OD tablet.
Enomoto naika clinic0 个研究点目标入组 60 人开始时间: 2014年7月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Dementia patients except Alzheimer's disease 2.Patients who have severe mental disorder 3.Patients who are pregnant or trying to get pregnant, or during breastfeeding 4.Patients with a history of the hypersensitivity for Memantine hydrochloride tablets 5.The case that a investigator judged to be inappropriate
研究者
相似试验
已完成
不适用
Prospective observational study in patients with spinal and bulbar muscular atrophy (SBMA) who completed the phase 3 clinical trial of TAP-144-SR (3M) .Spinal and Bulbar Muscular AtrophyJPRN-UMIN000003444eurology, the University of Tokyo Hospital18
招募中
Unknown
Clinical observation on the treatment of moderate female stress urinary incontinence with optimized formula of Qishi granules based on the theory of spleen kidney correlatioFemale stress urinary incontinenceITMCTR2024000008Xiyuan Hospital, China Academy of Chinese Medical Sciences
已完成
不适用
Observational cohort study in patients with severe asthma based on clinical phenotypesBronchial asthmaJPRN-UMIN000003254Division of Respiratory Medicine, Department of Internal Medicine, Hokkaido University Graduate School of Medicine300
进行中（未招募）
不适用
A phase II study for the treatment of patients with splenic marginal lymphoma with the combination of Cyclophosfamide, Vincristine, Liposomal Doxorubicin, Predinisone and RituximabTreatment of patients with newly diagnosed splenic marginal non Hodgkin lymphomaMedDRA version: 9.1Level: LLTClassification code 10062113Term: Splenic marginal zone lymphomaEUCTR2005-000693-45-ITG.I.S.L. - GRUPPO ITALIANO STUDIO LINFOMI
招募中
不适用
A prospective observational study for patients with community-acquired, health-care-associated, hospital-acquired, and ventilator-associated pneumonia in a Japanese University Hospitalcommunity-acquired (CAP), health-care-associated (HCAP), hospital-acquired (HAP), and ventilator-associated pneumonia (VAP)JPRN-UMIN000007090Department of Respiratory Medicine, Nagoya University Graduate School of Medicine1,420